$2.62 Billion is the total value of PFM Health Sciences, LP's 80 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 45.6% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
JNJ | Buy | JOHNSON & JOHNSON | $109,180,000 | +5.3% | 615,064 | +5.2% | 4.16% | +7.5% |
CYTK | CYTOKINETICS INC | $96,850,000 | +6.7% | 2,465,016 | 0.0% | 3.70% | +8.9% | |
LLY | LILLY ELI & CO | $96,829,000 | +13.2% | 298,643 | 0.0% | 3.69% | +15.5% | |
CNC | CENTENE CORP DEL | $94,127,000 | +0.5% | 1,112,480 | 0.0% | 3.59% | +2.5% | |
JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $89,228,000 | +11.0% | 571,936 | +10.8% | 3.40% | +13.2% |
MRK | New | MERCK & CO INC | $88,617,000 | – | 971,998 | +100.0% | 3.38% | – |
HZNP | HORIZON THERAPEUTICS PUB L | $87,085,000 | -24.2% | 1,091,840 | 0.0% | 3.32% | -22.7% | |
RCUS | Sell | ARCUS BIOSCIENCES INC | $84,799,000 | -21.7% | 3,346,458 | -2.5% | 3.24% | -20.1% |
HUM | HUMANA INC | $77,731,000 | +7.6% | 166,066 | 0.0% | 2.96% | +9.7% | |
PFE | PFIZER INC | $70,434,000 | +1.3% | 1,343,384 | 0.0% | 2.69% | +3.3% | |
BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $69,559,000 | +25.6% | 839,371 | +16.8% | 2.65% | +28.2% |
AVTR | AVANTOR INC | $64,677,000 | -8.0% | 2,079,657 | 0.0% | 2.47% | -6.2% | |
UNH | UNITEDHEALTH GROUP INC | $57,297,000 | +0.7% | 111,554 | 0.0% | 2.19% | +2.8% | |
IRTC | IRHYTHM TECHNOLOGIES INC | $53,337,000 | -31.4% | 493,721 | 0.0% | 2.04% | -30.0% | |
AXSM | New | AXSOME THERAPEUTICS INC | $52,111,000 | – | 1,360,596 | +100.0% | 1.99% | – |
SGEN | New | SEAGEN INC | $49,967,000 | – | 282,395 | +100.0% | 1.91% | – |
IQV | IQVIA HLDGS INC | $48,106,000 | -6.1% | 221,696 | 0.0% | 1.84% | -4.3% | |
DVAX | DYNAVAX TECHNOLOGIES CORP | $47,910,000 | +16.1% | 3,805,370 | 0.0% | 1.83% | +18.5% | |
BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $45,566,000 | -0.9% | 45,910,000 | 0.0% | 1.74% | +1.0% | ||
DHR | DANAHER CORPORATION | $44,541,000 | -13.6% | 175,690 | 0.0% | 1.70% | -11.8% | |
QURE | Buy | UNIQURE NV | $41,686,000 | +331.5% | 2,236,370 | +318.3% | 1.59% | +340.4% |
AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $41,088,000 | -6.4% | 48,150,000 | 0.0% | 1.57% | -4.6% | ||
MOH | MOLINA HEALTHCARE INC | $40,202,000 | -16.2% | 143,779 | 0.0% | 1.53% | -14.4% | |
VEEV | New | VEEVA SYS INC | $40,081,000 | – | 202,387 | +100.0% | 1.53% | – |
ICUI | Buy | ICU MED INC | $39,813,000 | -18.9% | 242,185 | +9.8% | 1.52% | -17.3% |
ARGX | New | ARGENX SEsponsored adr | $39,681,000 | – | 104,732 | +100.0% | 1.51% | – |
WAT | WATERS CORP | $38,935,000 | +6.6% | 117,634 | 0.0% | 1.48% | +8.8% | |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $38,109,000 | +27.0% | 576,800 | +27.5% | 1.45% | +29.6% |
ABBV | New | ABBVIE INC | $37,713,000 | – | 246,235 | +100.0% | 1.44% | – |
CI | Buy | CIGNA CORP NEW | $37,235,000 | +65.1% | 141,300 | +50.1% | 1.42% | +68.4% |
MCK | MCKESSON CORP | $34,517,000 | +6.6% | 105,811 | 0.0% | 1.32% | +8.8% | |
ICLR | ICON PLC | $34,278,000 | -10.9% | 158,183 | 0.0% | 1.31% | -9.1% | |
New | BIOGEN INCcall | $34,017,000 | – | 166,800 | +100.0% | 1.30% | – | |
TMO | THERMO FISHER SCIENTIFIC INC | $33,761,000 | -8.0% | 62,143 | 0.0% | 1.29% | -6.2% | |
CAH | CARDINAL HEALTH INC | $33,441,000 | -7.8% | 639,783 | 0.0% | 1.28% | -5.9% | |
Buy | ERASCA INC | $32,759,000 | -20.5% | 5,881,382 | +22.7% | 1.25% | -18.9% | |
Buy | CARIBOU BIOSCIENCES INC | $32,580,000 | -18.8% | 6,000,000 | +37.3% | 1.24% | -17.1% | |
BDX | Sell | BECTON DICKINSON & CO | $32,221,000 | -23.1% | 130,697 | -17.1% | 1.23% | -21.6% |
EW | EDWARDS LIFESCIENCES CORP | $32,155,000 | -19.2% | 338,155 | 0.0% | 1.23% | -17.6% | |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $31,966,000 | -50.0% | 317,411 | -28.1% | 1.22% | -49.0% |
NVRO | Buy | NEVRO CORP | $28,902,000 | -38.5% | 659,410 | +1.5% | 1.10% | -37.2% |
THC | TENET HEALTHCARE CORP | $28,623,000 | -38.9% | 544,583 | 0.0% | 1.09% | -37.6% | |
CTLT | Sell | CATALENT INC | $23,428,000 | -17.5% | 218,366 | -14.7% | 0.89% | -15.8% |
BCRX | New | BIOCRYST PHARMACEUTICALS INC | $22,878,000 | – | 2,162,411 | +100.0% | 0.87% | – |
PEN | Buy | PENUMBRA INC | $22,761,000 | -38.5% | 182,786 | +9.6% | 0.87% | -37.3% |
MYGN | Sell | MYRIAD GENETICS INC | $21,391,000 | -54.9% | 1,177,250 | -37.5% | 0.82% | -54.0% |
BAX | New | BAXTER INTL INC | $20,805,000 | – | 323,907 | +100.0% | 0.79% | – |
ANTM | ELEVANCE HEALTH INC | $20,623,000 | -1.8% | 42,734 | 0.0% | 0.79% | +0.3% | |
GBIO | Buy | GENERATION BIO CO | $18,193,000 | +331.6% | 2,773,313 | +382.9% | 0.69% | +339.2% |
PMVP | Buy | PMV PHARMACEUTICALS INC | $17,302,000 | +86.2% | 1,214,164 | +172.1% | 0.66% | +90.2% |
KRTX | Sell | KARUNA THERAPEUTICS INC | $16,483,000 | -37.2% | 130,293 | -37.1% | 0.63% | -35.9% |
ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $15,487,000 | +216.6% | 9,109,780 | +283.6% | 0.59% | +223.0% |
VERV | Buy | VERVE THERAPEUTICS INC | $12,914,000 | +53.0% | 845,186 | +128.6% | 0.49% | +56.0% |
New | KARUNA THERAPEUTICS INCcall | $12,651,000 | – | 100,000 | +100.0% | 0.48% | – | |
JNCE | Sell | JOUNCE THERAPEUTICS INC | $11,967,000 | -55.6% | 3,949,668 | -0.6% | 0.46% | -54.7% |
New | PROCEPT BIOROBOTICS CORP | $11,686,000 | – | 357,492 | +100.0% | 0.45% | – | |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $11,174,000 | -68.5% | 580,768 | -71.6% | 0.43% | -67.9% |
ITOS | New | ITEOS THERAPEUTICS INC | $11,082,000 | – | 537,954 | +100.0% | 0.42% | – |
OSH | Buy | OAK STR HEALTH INC | $10,172,000 | -27.7% | 618,761 | +18.2% | 0.39% | -26.2% |
Buy | IO BIOTECH INC | $10,083,000 | +51.6% | 2,159,155 | +58.5% | 0.38% | +54.6% | |
PRTA | New | PROTHENA CORP PLC | $9,370,000 | – | 345,114 | +100.0% | 0.36% | – |
ISEE | Sell | IVERIC BIO INC | $8,716,000 | -48.5% | 906,016 | -9.9% | 0.33% | -47.6% |
NTLA | Sell | INTELLIA THERAPEUTICS INC | $8,451,000 | -59.6% | 163,280 | -43.3% | 0.32% | -58.8% |
PRAX | Buy | PRAXIS PRECISION MEDICINES I | $8,079,000 | -8.5% | 3,297,347 | +281.3% | 0.31% | -6.7% |
New | DYNAVAX TECHNOLOGIES CORPnote 2.500% 5/1 | $7,479,000 | – | 5,000,000 | +100.0% | 0.28% | – | |
EDIT | New | EDITAS MEDICINE INC | $7,449,000 | – | 629,684 | +100.0% | 0.28% | – |
HOWL | Buy | WEREWOLF THERAPEUTICS INC | $7,079,000 | +174.9% | 1,730,723 | +195.7% | 0.27% | +181.2% |
New | SEAGEN INCcall | $7,078,000 | – | 40,000 | +100.0% | 0.27% | – | |
New | SIGHT SCIENCES INC | $6,979,000 | – | 776,281 | +100.0% | 0.27% | – | |
Sell | SOPHIA GENETICS SAordinary shares | $6,393,000 | -58.9% | 1,766,062 | -12.3% | 0.24% | -58.1% | |
SANA | Buy | SANA BIOTECHNOLOGY INC | $6,126,000 | +108.7% | 952,733 | +168.2% | 0.23% | +112.7% |
New | BIOCRYST PHARMACEUTICALS INCcall | $5,819,000 | – | 550,000 | +100.0% | 0.22% | – | |
ACAD | New | ACADIA PHARMACEUTICALS INC | $5,425,000 | – | 384,995 | +100.0% | 0.21% | – |
AERI | Sell | AERIE PHARMACEUTICALS INC | $5,246,000 | -47.0% | 699,531 | -35.7% | 0.20% | -45.9% |
BLSA | BCLS ACQUISITION CORP | $4,595,000 | +0.3% | 464,103 | 0.0% | 0.18% | +2.3% | |
JYAC | JIYA ACQUISITION CORP | $4,585,000 | +0.5% | 464,103 | 0.0% | 0.18% | +2.3% | |
CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $4,250,000 | – | 392,764 | +100.0% | 0.16% | – |
EPIX | New | ESSA PHARMA INC | $3,029,000 | – | 961,716 | +100.0% | 0.12% | – |
Buy | PARDES BIOSCIENCES INC | $2,460,000 | -53.3% | 801,204 | +9.7% | 0.09% | -52.3% | |
FLDM | Exit | FLUIDIGM CORP DEL | $0 | – | -980,505 | -100.0% | -0.13% | – |
CCCC | Exit | C4 THERAPEUTICS INC | $0 | – | -284,772 | -100.0% | -0.26% | – |
CANO | Exit | CANO HEALTH INC | $0 | – | -1,301,937 | -100.0% | -0.31% | – |
GILD | Exit | GILEAD SCIENCES INC | $0 | – | -249,884 | -100.0% | -0.56% | – |
DXCM | Exit | DEXCOM INC | $0 | – | -37,021 | -100.0% | -0.71% | – |
HCA | Exit | HCA HEALTHCARE INC | $0 | – | -80,128 | -100.0% | -0.75% | – |
HRTX | Exit | HERON THERAPEUTICS INC | $0 | – | -3,512,348 | -100.0% | -0.75% | – |
SRRA | Exit | SIERRA ONCOLOGY INC | $0 | – | -1,062,888 | -100.0% | -1.27% | – |
Exit | GILEAD SCIENCES INCcall | $0 | – | -1,412,500 | -100.0% | -3.14% | – | |
OM | Exit | OUTSET MED INC | $0 | – | -2,810,686 | -100.0% | -4.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
HUMANA INC | 37 | Q3 2023 | 3.8% |
EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
PENUMBRA INC | 33 | Q3 2023 | 4.8% |
AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
Erasca, Inc. | February 14, 2023 | ? | ? |
Generation Bio Co. | February 14, 2023 | ? | ? |
IO Biotech, Inc. | February 14, 2023 | ? | ? |
Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
Outset Medical, Inc. | February 14, 2023 | ? | ? |
uniQure N.V. | February 14, 2023 | ? | ? |
AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.